Your browser doesn't support javascript.
loading
A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for a cisplatin-containing regimen. - PATROL-I.
Tsuji, Daiki; Nakagaki, Shigeru; Yonezawa, Itsuki; Suzuki, Kenichi; Yokokawa, Takashi; Kawasaki, Yohei; Yamaguchi, Takumi; Kawaguchi, Takashi; Hatori, Masahiro; Matsumoto, Takuma; Sakata, Yukio; Yamamoto, Keisuke; Nishimura, Tomoyasu; Kogure, Yuki; Hayashi, Toshinobu; Osawa, Misa; Itoh, Kunihiko; Watanabe, Masaya.
Affiliation
  • Tsuji D; Department of Clinical Pharmacology & Genetics, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan. d-tsuji@u-shizuoka-ken.ac.jp.
  • Nakagaki S; Department of Pharmacy, Shizuoka General Hospital, Shizuoka, Japan.
  • Yonezawa I; Department of Clinical Pharmacology & Genetics, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan.
  • Suzuki K; Department of Clinical Pharmacology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
  • Yokokawa T; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Kawasaki Y; Faculty of Nursing, Japanese Red Cross College of Nursing, Tokyo, Japan.
  • Yamaguchi T; Institute for Assistance of Academic and Education, IAAE, Kanagawa, Japan.
  • Kawaguchi T; Department of Practical Pharmacy, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
  • Hatori M; Department of Pharmacy, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Matsumoto T; Pharmaceutical Department, National Hospital Organization Iwakuni Clinical Center, Yamaguchi, Japan.
  • Sakata Y; Department of Pharmacy, Hakodate Municipal Hospital, Hokkaido, Japan.
  • Yamamoto K; Department of Pharmacy, Seirei Hamamatsu General Hospital, Shizuoka, Japan.
  • Nishimura T; Department of Pharmacy, Wakayama Medical University Hospital, Wakayama, Japan.
  • Kogure Y; Department of Pharmacy, National Hospital Organization Higashihiroshima Medical Center, Hiroshima, Japan.
  • Hayashi T; Department of Pharmaceutical and Health Care Management, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan.
  • Osawa M; Department of Pharmacy, Shizuoka General Hospital, Shizuoka, Japan.
  • Itoh K; Department of Clinical Pharmacology & Genetics, School of Pharmaceutical Sciences, University of Shizuoka, Suruga-ku, Shizuoka, Japan.
  • Watanabe M; Department of Gastroenterological Surgery, Shizuoka General Hospital, Shizuoka, Japan.
Invest New Drugs ; 42(1): 44-52, 2024 Feb.
Article in En | MEDLINE | ID: mdl-38055127
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antiemetics Limits: Humans Language: En Year: 2024 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Antiemetics Limits: Humans Language: En Year: 2024 Type: Article